Nextki 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Nextki 50 mg Tablet

Nextki 50 mg Tablet

Nextki 50 mg Tablet contains dasatinib and is an oral anticancer medicine used to treat certain types of blood cancer. It works by blocking abnormal tyrosine kinase proteins that help cancer cells grow and multiply. The tablet is taken by mouth under the direction of a qualified healthcare professional.

BUY NOW

Category

Dasatinib is a tyrosine kinase inhibitor that targets BCR-ABL and other kinase proteins involved in leukemia cell growth. Nextki 50 mg Tablet is used in appropriate patients with Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. The medicine can be taken with or without food and should be used consistently according to the prescribed treatment schedule. Regular blood tests and medical monitoring may be needed to assess blood cell counts and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Therapeutic Class Tyrosine Kinase Inhibitor
Pack Size 60 tablets

Product Also Known As

Nextki 50 mg, Nextki 50 mg Tablet, Nextki 50mg Tablet, Dasatinib 50 mg Tablet, Dasatinib Tablets, Dasatinib 50mg, Tyrosine Kinase Inhibitor Tablet